Adam M. Veness - 02 May 2022 Form 4 Insider Report for Cyteir Therapeutics, Inc.

Role
General Counsel
Signature
/s/ Adam M. Veness
Issuer symbol
N/A
Transactions as of
02 May 2022
Net transactions value
$0
Form type
4
Filing time
04 May 2022, 16:22:07 UTC
Previous filing
04 May 2022
Next filing
07 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYT Stock Option (Right to buy) Award $0 +177,000 $0.000000 177,000 02 May 2022 Common Stock 177,000 $2.35 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock underlying this stock option award vest as to 25% on April 25, 2023, and 2.083% in 36 monthly installments thereafter, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date.